Interaction of gamma-irradiation with two new antineoplastic agents, aziridinylbenzoquinone (AZQ) and 4'- (acridinylamino)methanesulfon-m-anisidide (AMSA), in murine tumors in vivo.
D000609:Aminoacridines / Q000627:therapeutic use*; D000677:Amsacrine; D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001388:Aziridines / Q000627:therapeutic use*; D001389:Azirines / Q000627:therapeutic use*; D016227:Benzoquinones; D002470:Cell Survival / Q000187:drug effects / Q000528:radiation effects; D053138:Cyclohexenes; D007941:Leukemia P388 / Q000188:drug therapy* / Q000532:radiotherapy; D007942:Leukemia, Experimental / Q000188:drug therapy*; D008545:Melanoma / Q000188:drug therapy* / Q000532:radiotherapy; D051379:Mice; D009374:Neoplasms, Experimental / Q000188:drug therapy; D011809:Quinones / Q000627:therapeutic use*; D011838:Radiation-Sensitizing Agents; D011867:Radioisotope Teletherapy
D000609:Aminoacridines; D000970:Antineoplastic Agents; D001388:Aziridines; D001389:Azirines; D016227:Benzoquinones; D053138:Cyclohexenes; D011809:Quinones; D011838:Radiation-Sensitizing Agents; D000677:Amsacrine; C006052:2,5-bis(1-aziridinyl)-3,6-bis(2-methoxyethoxy)-4-benzoquinone